Shannon Sheu, MD
Dermatology · Honolulu, HINPI 1700821667
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 250 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,477, 2.3 times the $645 reported in 2019.
Across 250 payments — averaging $23.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$733
- Regeneron Healthcare Solutions, Inc.$681
- Amgen$586
- UCB, Inc.$381
- Galderma Laboratories, L.p.$323
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,932100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $1,227 |
| Lilly USA, LLC | 27 | $733 |
| Regeneron Healthcare Solutions, Inc. | 19 | $681 |
| Amgen | 30 | $586 |
| UCB, Inc. | 17 | $381 |
| Galderma Laboratories, L.p. | 16 | $323 |
| Sanofi | 9 | $273 |
| E.r. Squibb & Sons, L.L.C. | 10 | $245 |
| Incyte Corporation | 10 | $242 |
| Novartis | 11 | $239 |
| Merz North America, Inc. | 9 | $215 |
| Sun Pharmaceutical Industries Inc. | 9 | $199 |
| LEO Pharma Inc. | 5 | $135 |
| Solta Medical, A Division Of Bausch Health US, LLC | 4 | $84 |
| Biofrontera Inc. | 4 | $70 |
| Bristol Myers Squibb | 3 | $64 |
| Pfizer | 3 | $56 |
| Organon | 2 | $54 |
| Johnson & Johnson | 1 | $29 |
| Dermira, Inc. | 1 | $28 |
| Journey Medical Corporation | 1 | $28 |
| Revance Therapeutics, Inc. | 1 | $28 |
| Almirall LLC | 1 | $16 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $14 |
How this compares
$5,950 in reported general payments places this provider in the 65th percentile of 67 dermatology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 11 | $81,014 |
| Tacrolimus | 16 | $2,791 |
| Halobetasol Propionate | 59 | $2,486 |
| Doxycycline Hyclate | 15 | $1,527 |
| Fluorouracil | 23 | $1,475 |
| Clobetasol Propionate | 27 | $1,417 |
| Fluocinonide | 27 | $1,038 |
| Metronidazole | 13 | $839 |
| Desonide | 16 | $667 |
| Ketoconazole | 48 | $515 |
| Triamcinolone Acetonide | 35 | $397 |
| MethotrexateMethotrexate Sodium | 13 | $397 |
| Mupirocin | 30 | $204 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 19 | $180 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Honolulu
- Sarah HowellHonolulu$653K
- Douglas JohnsonHonolulu$568K
- Ryan SatoHonolulu$226K
- Greg SakamotoHonolulu$20K
- Kory KitagawaHonolulu$18K
- Kevin DawsonHonolulu$16K
- Dylan LeeHonolulu$15K
- Sarah GrekinHonolulu$13K
- Gregory HerbichHonolulu$12K
- Stella MatsudaHonolulu$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.